Why Oncologists Recommend Geftinat 250mg for EGFR-Positive Lung Cancer

0
975

Lung Cancer is one of the most commonly found diseases in the USA and is increasing globally. Geftinat 250mg for Lung Cancer is the chemical-based medication that especially  treats Non-Small Cell Lung Cancer (NSCL). NSCL are in the majority as compared to Small Cell Lung Cancer (SCL) among the overall Lung Cancer cases.

Lung Cancer refers to uncontrollable growth of cells on the inner lining of the lungs. The mutation of the Endothelial Growth Factor Receptor (EGFR) mainly causes it, and this receptor is responsible for cell growth and division.

How Geftinat Helps EGFR Mutated Patients ?  

Oncologists recommend this medicine to treat Non Small Cell Lung Cancer. The mutation in the EGFR leads to an abnormal reaction with its growth factor producing defective protein; therefore, it causes cancer. This medicine's salt Gefitinib is a type of Tyrosine Kinase Inhibitor that blocks the EGFR. As a result, there is no binding of the endothelial growth factor to its receptor, preventing cell growth and division. Ultimately, it stops proliferation and cures cancer.

Advantages of Geftinat Therapy over other Therapy  

Geftinat Therapy offers several advantages as compared to other conventional therapies. Following is the list of advantages offered by Geftinat Tablet:

  • High Specificity

  • Target Based Therapy

  • Comparatively More Effective

  • Less Side Effects

 

Dosage and Usage  

Doctor suggests the dosage of this medicine according to the person's health condition and body tolerance. On the whole, dosage varies from person to person. This chemical-based drug is available on the market in the form of tablets and should be taken with water to swallow it whole. Ensure no biting, no chewing, and no breaking of tablet as it reduces efficacy and may lead to certain side effects also.

Conclusion   

Lung cancer cases are increasing globally, among which the majority of the cases are of Non Small Cell Lung Cancer, and thus need this medicine at a lower cost for easy consumption to cure the disease. To get a heavy discount on Geftinat 250mg Tablet price, Visit Magicine Pharma as it offers prescribed medicine from trusted sources and fast delivery.

FAQs   

Q-What are the side effects of Geftinat Tablet?
A-The side effects of this medicine are fever, nausea, redness around fingernails, eye irritation, etc.

Q-Can pregnant women consume Geftinat 250mg?
A-This tablet harms a growing baby; therefore, doctors advise not to consume it during pregnancy.

Q-What is the use of Geftinat 250mg Tablet in NSCL?
A-It blocks the EGFR that prevents the release of abnormal protein that causes cancer , henceforth cures cancer.

Patrocinado
Pesquisar
Categorias
Leia mais
Outro
Southeast Asia Cloud Computing Market Size, Growth, Analysis & Forecast Report, 2033 | UnivDatos
According to a new report by UnivDatos, The Southeast Asia Cloud Computing Market is...
Por univdatos 2025-12-04 08:46:16 0 168
Outro
What Makes Cheese Paper the Best Choice for Cheese Storage?
Cheese is a piece of art, and each one should be treated in a way that adds more flavor and...
Por jmaes 2025-10-20 10:23:04 0 811
Outro
Medical Writing Market Expanding Through Rising Clinical Research, Regulatory Documentation Needs, and Digital Healthcare Communication
The latest business intelligence report released by Polaris Market Research on Medical...
Por nilajadhav312 2025-11-28 10:19:34 0 211
Health
Buy Oxycodone Online Safely A Complete Guide to Legal Access and Patient Safety
Oxycodone is a prescription opioid used to treat moderate to severe pain, often following...
Por smithamelia7540 2025-12-13 11:54:00 0 62
Outro
Advanced Air Mobility Market Growth, Size, Analysis, Trends And Forecast to 2032
Advanced Air Mobility refers to new-age technologies which focuses on how to transform air-based...
Por davidthamus55 2025-08-28 13:25:31 0 1KB
Patrocinado
Telodosocial – Condividi ricordi, connettiti e crea nuove amicizie,eldosocial – Share memories, connect and make new friends https://telodosocial.it